shutterstock 1179311575 450x300 rmJVt6

The complexity and rewards of gene treatments for rare diseases

​ ​ 

Gene therapies can transform the approach to rare diseases and improve the quality of life for patients. But developing and accessing them is hampered by regulatory burdens, cost and reimbursment schemes.

In this special report, Euractiv takes a look at gene treatment approaches across countries, and examines the EU’s approach to such therapies for rare diseases.

EU needs to step up to unleash gene therapies potential, stakeholders say

News Health
30-11–0001

Est. 5min

While gene therapies have the potential to transform the approach to rare diseases and improve the quality of life for patients, stakeholders and patients complain that they are very expensive to develop and difficult to access.

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *